SG Holdings Co에 대한 매도 수량은 투자자에게 SG Holdings Co의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

SG Holdings Co (OTC:SGHHF) 주식, 공매도 수량 보고

SG Holdings Co Ltd along with its subsidiaries provides logistics-oriented one-stop solutions. The company is also engaged in Real estate to make effective use of real estate and facilities infrastructure centering on logistics, Automobile business in order to manufacture eco-specification vehicles, Human resource business to improve operations and improve service quality by sorting work at delivery bases, and it is also engaged in other business such as finance, IT, and human resource development.

SG Holdings Co Ltd

In the last three months, 6 analysts have published ratings on Winnebago Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>), offering a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $68.0, a high estimate of $70.00, and a low estimate of $64.00. Experiencing a 4.67% decline, the current average is now lower than the previous average price target of $71.33. 
<img src="https://www.benzinga.com/files/images/story/2024/1734976859_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Winnebago Industries. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Albanese</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$70.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$64.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Michael Albanese</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$70.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Tristan Thomas-Martin</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Craig Kennison</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$64.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Michael Albanese</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$70.00</td>
<td>$75.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Winnebago Industries. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Winnebago Industries compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Winnebago Industries's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Winnebago Industries's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/WGO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Winnebago Industries analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Winnebago Industries's Background</h2>
Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.
<h3>A Deep Dive into Winnebago Industries's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Winnebago Industries's revenue growth over a period of 3 months has faced challenges. As of 31 August, 2024, the company experienced a revenue decline of approximately -6.5%. This indicates a decrease in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Winnebago Industries's net margin excels beyond industry benchmarks, reaching -4.04%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Winnebago Industries's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -2.25% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Winnebago Industries's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.21% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Winnebago Industries's debt-to-equity ratio is below the industry average at 0.58, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Assessing Winnebago Industries: Insights From 6 Financial Analysts

12 analysts have shared their evaluations of Waters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAT#NYSE">WAT</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">8</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Waters and provided 12-month price targets. The average target is $380.83, accompanied by a high estimate of $430.00 and a low estimate of $325.00. This current average reflects an increase of 10.53% from the previous average price target of $344.55. 
<img src="https://www.benzinga.com/files/images/story/2024/1734976853_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Waters among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sung Ji Nam</td>
<td>Scotiabank</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$430.00</td>
<td>-</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$430.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Justin Bowers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$325.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Eve Burstein</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$360.00</td>
<td>$345.00</td>
</tr>
<tr>
<td>Dan Brennan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$410.00</td>
<td>$363.00</td>
</tr>
<tr>
<td>Daniel Arias</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$360.00</td>
<td>$332.00</td>
</tr>
<tr>
<td>Rachel Vatnsdal</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$380.00</td>
<td>$340.00</td>
</tr>
<tr>
<td>Brandon Couillard</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$415.00</td>
<td>$380.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$360.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$330.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Tycho Peterson</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$415.00</td>
<td>$355.00</td>
</tr>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$355.00</td>
<td>$335.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Waters. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Waters compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Waters's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Waters's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/WAT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Waters analyst ratings.</a>
<h2>All You Need to Know About Waters</h2>
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
<h3>Financial Insights: Waters</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3 months period, Waters showcased positive performance, achieving a revenue growth rate of 4.02% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 21.82%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Waters's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.71% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Waters's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.6% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 1.19, Waters faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Waters Stock

Throughout the last three months, 39 analysts have evaluated Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">11</td>
<td align="right">7</td>
<td align="right">21</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">6</td>
<td align="right">4</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">10</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $85.72, a high estimate of $110.00, and a low estimate of $70.00. Experiencing a 2.77% decline, the current average is now lower than the previous average price target of $88.16. 
<img src="https://www.benzinga.com/files/images/story/2024/1734976840_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Nike by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jonathan Komp</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Jim Duffy</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$75.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Joseph Civello</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Alex Straton</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$74.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Krisztina Katai</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$84.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Lorraine Hutchinson</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Tom Nikic</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$84.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Cristina Fernandez</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$80.00</td>
<td>$93.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$92.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Michael Binetti</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$97.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Krisztina Katai</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$82.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Cristina Fernandez</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$93.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Alex Straton</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$79.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Lorraine Hutchinson</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$95.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Tom Nikic</td>
<td>Needham</td>
<td>Announces</td>
<td>Buy</td>
<td>$84.00</td>
<td>-</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$73.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Piral Dadhania</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$80.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Joseph Civello</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$97.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$81.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$78.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Robert Drbul</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Krisztina Katai</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$92.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$77.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Cristina Fernandez</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$96.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Piral Dadhania</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$82.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Michael Binetti</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Joseph Civello</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$83.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Lorraine Hutchinson</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$100.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Randal Konik</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$85.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Joseph Civello</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Hold</td>
<td>$85.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Alex Straton</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$82.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Piral Dadhania</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$85.00</td>
<td>$75.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Nike. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Nike compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Nike's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Nike's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NKE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Nike analyst ratings.</a>
<h2>All You Need to Know About Nike</h2>
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
<h3>Nike's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Over the 3 months period, Nike showcased positive performance, achieving a revenue growth rate of 6.6% as of 30 November, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Nike's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.41% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Nike's ROE excels beyond industry benchmarks, reaching 8.31%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Nike's ROA stands out, surpassing industry averages. With an impressive ROA of 3.07%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a high debt-to-equity ratio of 0.86, Nike faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Nike's Future

In the last three months, 18 analysts have published ratings on Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>), offering a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">5</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $191.72, a high estimate of $220.00, and a low estimate of $164.00. This upward trend is apparent, with the current average reflecting a 4.43% increase from the previous average price target of $183.59.
<img src="https://www.benzinga.com/files/images/story/2024/1734976826_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive Darden Restaurants is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Harbour</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$209.00</td>
<td>$193.00</td>
</tr>
<tr>
<td>Sara Senatore</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$211.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Andrew Strelzik</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$175.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Brian Bittner</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$200.00</td>
<td>$182.00</td>
</tr>
<tr>
<td>Chris O'Cull</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$205.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Jake Bartlett</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$200.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$210.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$206.00</td>
<td>$192.00</td>
</tr>
<tr>
<td>Eric Gonzalez</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$194.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$194.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Nick Setyan</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$175.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$164.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Andrew Strelzik</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$165.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$164.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Neutral</td>
<td>$183.00</td>
<td>-</td>
</tr>
<tr>
<td>Jon Tower</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$206.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$164.00</td>
<td>$164.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Darden Restaurants. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Darden Restaurants compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Darden Restaurants's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Darden Restaurants's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DRI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Darden Restaurants analyst ratings.</a>
<h2>Unveiling the Story Behind Darden Restaurants</h2>
Darden Restaurants is the largest restaurant operator in the us full-service space, with consolidated revenue of $11.4 billion in fiscal 2024 resulting in 3%-4% full-service market share (per NRA data and our calculations). The company maintains a portfolio of 10 restaurant brands: Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Ruth's Chris, Yard House, The Capital Grille, Seasons 52, Eddie V's, Bahama Breeze, and The Capital Burger. Darden generates revenue almost exclusively from company-owned restaurants, though a small network of franchised restaurants and consumer-packaged goods sales through the traditional grocery channel contribute modestly. As of the end of its fiscal 2024, the company operated 2,031 restaurants in the us.
<h3>Financial Milestones: Darden Restaurants's Journey</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Positive Revenue Trend: Examining Darden Restaurants's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.82% as of 30 November, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Darden Restaurants's net margin is impressive, surpassing industry averages. With a net margin of 7.44%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Darden Restaurants's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 10.21%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Darden Restaurants's ROA stands out, surpassing industry averages. With an impressive ROA of 1.8%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Darden Restaurants's debt-to-equity ratio is below the industry average. With a ratio of 3.06, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Darden Restaurants's Future

Truist Finl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) short percent of float has risen 41.67% since its last report. The company recently reported that it has 17.98 million shares sold short, which is 1.36% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.34 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Truist Finl Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734976824_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Truist Finl has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Truist Finl's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Truist Finl's peer group average for short interest as a percentage of float is 3.74%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

(TFC) - Analyzing Truist Finl's Short Interest

American Superconductor's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMSC#NYSE">AMSC</a>) short percent of float has fallen 8.05% since its last report. The company recently reported that it has 2.64 million shares sold short, which is 6.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.25 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>American Superconductor Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734976818_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for American Superconductor has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing American Superconductor's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, American Superconductor's peer group average for short interest as a percentage of float is 10.11%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

AMSC

Looking Into American Superconductor's Recent Short Interest

RAPT Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) shares are trading higher after the company disclosed a partnership with Shanghai Jemincare Pharmaceutical.
The collaboration is for an exclusive license agreement to develop and commercialize RPT904, a novel anti-IgE monoclonal antibody worldwide, excluding mainland <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42643847/rapt-therapeutics-and-shanghai-jemincare-pharmaceutical-announce-exclusive-license-agreement-for-n" rel="noreferrer noopener">China, Hong Kong, Macau, and Taiwan</a>.
RPT904 is designed to provide a potential alternative to omalizumab (Xolair), addressing allergic conditions such as asthma and chronic spontaneous urticaria (CSU).
As per the deal, Jemincare will receive a $35 million upfront payment, up to $672.5 million in regulatory and commercial milestone payments, and royalties on sales outside the Jemincare Territory.
RAPT plans to focus on developing RPT904 for food allergies, while Jemincare is conducting Phase 2 trials in China for asthma and CSU.
Jemincare has completed a Phase 1 study of JYB1904 in 56 healthy volunteers in China, evaluating safety, pharmacokinetics (PK), and pharmacodynamics (PD).
Jemincare is now running two Phase 2 trials in China. The asthma trial focuses on PK and PD comparisons with omalizumab, with topline data expected in late 2025. The CSU trial targets safety and efficacy, with results anticipated in early 2026.
Brian Wong, M.D., Ph.D., President and CEO of RAPT said, &#8220;We&#8217;re delighted to partner with Jemincare and excited by RPT904 and its potential to be a novel best-in-class treatment option for patients with food allergy. Omalizumab&#8217;s rapid uptake in food allergy since its approval earlier this year confirms the high unmet need and large opportunity in this growing market.&#8221;
&#8220;RPT904 targets the same clinically validated epitope as omalizumab and combined with extended half-life, gives this molecule a best-in-class profile. We plan to initiate a Phase 2b clinical trial of RPT904 in food allergy in the second half of 2025.&#8221;
In a separate release, RAPT Therapeutics disclosed a securities purchase agreement with accredited investors for a private <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42644085/rapt-therapeutics-announces-150-million-private-placement" rel="noreferrer noopener">placement valued at around $150 million</a>.
The agreement includes 100 million common shares priced at $0.85 each and pre-funded warrants for up to 76.45 million shares priced at $0.8499 each.
The pre-funded warrants, exercisable at $0.0001 per share, are immediately exercisable and remain valid until fully exercised.
The transaction is expected to close by December 27, 2024, pending customary conditions.
Price Action: RAPT shares are up 110.2% at $1.735 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42647650" target="_blank" rel="noreferrer noopener">Palantir Vs. Lockheed: A Tech-Fueled Showdown In The $850 Billion Defense Market</a></li>
</ul>

Equities

News

Financing

Contracts

Small Cap

Movers

RAPT

Why RAPT Therapeutics Stock Gained Over 100% On Monday?

Analysts' ratings for Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) over the last quarter vary from bullish to bearish, as provided by 14 analysts.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">8</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $293.29, a high estimate of $315.00, and a low estimate of $265.00. Highlighting a 0.58% decrease, the current average has fallen from the previous average price target of $295.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1734976812_0_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The perception of Danaher by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sung Ji Nam</td>
<td>Scotiabank</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$265.00</td>
<td>-</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$290.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Doug Schenkel</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$285.00</td>
<td>-</td>
</tr>
<tr>
<td>Conor McNamara</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$311.00</td>
<td>$333.00</td>
</tr>
<tr>
<td>Dan Brennan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$315.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Paul Knight</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$310.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Jacob Johnson</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$315.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Daniel Arias</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$265.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Dan Leonard</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$305.00</td>
<td>$309.00</td>
</tr>
<tr>
<td>Andrew Cooper</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$275.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Catherine Schulte</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$277.00</td>
<td>$278.00</td>
</tr>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$278.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Jacob Johnson</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$315.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Danaher. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Danaher compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Danaher's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Danaher's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DHR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Danaher analyst ratings.</a>
<h2>Delving into Danaher's Background</h2>
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
<h3>Breaking Down Danaher's Financial Performance</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Danaher's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 3.09%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Danaher's net margin excels beyond industry benchmarks, reaching 14.11%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Danaher's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.62% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Danaher's ROA excels beyond industry benchmarks, reaching 1.03%. This signifies efficient management of assets and strong financial health.
Debt Management: Danaher's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.34.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

14 Analysts Have This To Say About Danaher

Sunrun's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NYSE">RUN</a>) short percent of float has risen 3.82% since its last report. The company recently reported that it has 48.18 million shares sold short, which is 25.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.8 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Sunrun Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734976812_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Sunrun has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Sunrun's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Sunrun's peer group average for short interest as a percentage of float is 9.32%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Sunrun?

Happy Holidays, everyone!
I hope this newsletter finds you in great spirits, enjoying the festive season with your loved ones. This year, Christmas coincides with the first day of Hanukkah, a rare alignment that adds even more reason to celebrate.
While Thanksgiving remains my favorite holiday, Christmas holds a special place in my heart, and today, I want to give you a gift that will resonate well into 2025 and beyond: a roadmap to becoming a better investor by exploring a highly underappreciated corner of the market – community bank stocks.
Now, before you roll your eyes and declare this the dullest idea ever, let me assure you: while index funds and flashy AI stocks dominate headlines, community banks represent one of the few remaining inefficiencies in today's highly efficient market.
Let me show you.
In fact, Charlie Munger himself hinted at this path during a meeting years ago. He emphasized the need to seek opportunities in less-liquid, inefficient markets, areas where institutional investors fear to tread. This, my friends, describes community banks to a tee.
<h2 class="wp-block-heading">My Journey into Bank Stocks</h2>
My introduction to community bank stocks came about almost by accident while I was working for a small regional firm in Annapolis, Maryland.
This firm specialized in making markets for community banks and trading municipal bonds. A colleague in our office, a local legend of sorts, always seemed to have the Midas touch. He would stroll in at 9:29 a.m., just before the market opened, and was out the door well before happy hour began. Despite this seemingly casual approach, he was incredibly successful, with clients who were fiercely loyal to him.
Curious about his secret, I asked him one day how he managed to achieve such stellar results. His answer was simple but eye-opening: he traded local bank stocks.
This was back in the days before Regulation FD, when trading volumes were thin, and spreads were wide. A stock might be quoted at 10 bid and 12 offered. With a solid trading desk, you could buy at 10, sell at 12, and pocket the difference.
It was a lucrative business.
But the real magic came during the aftermath of the S&amp;L crisis in the early 1990s. These bank stocks often traded at 40%, 50%, or 60% of tangible book value. Then came the Riegle-Neal Interstate Banking and Branching Efficiency Act of 1994, which kicked off a wave of banking consolidation. Larger banks started snapping up smaller ones at premiums to book value.
Suddenly, these undervalued stocks became acquisition targets, creating significant returns for investors.
That's when I realized the immense potential in community bank stocks, a fascination that has stayed with me ever since.
<h2 class="wp-block-heading">Why Community Banks?</h2>
Let's start with the backdrop.
Community banks have been consolidating for decades, and the trend is far from over. We've gone from roughly 18,000 banks in the 1980s to about 5,000 today, yet that number is still too high for the industry to function efficiently.
Scale matters in banking. Larger banks enjoy better returns on assets, higher returns on equity, and a lower cost of regulatory compliance. This creates a continuous cycle of mergers and acquisitions, with about 4% of banks being acquired annually over the past 20 years.
Recent years have seen this pace slow, largely due to the anti-M&amp;A stance of the Biden administration. Lengthy deal approvals and increased regulatory scrutiny have held back consolidation, but this has created significant pent-up demand.
With regulatory conditions poised to become more favorable, the pace of M&amp;A activity is likely to accelerate, setting the stage for significant opportunities in the sector.
<h2 class="wp-block-heading">The Double Compounding Opportunity</h2>
Community bank stocks often trade below tangible book value, creating a margin of safety for investors.
Currently average around 1.28 times book value, but during peak M&amp;A cycles, multiples can reach as high as 1.75 or even 2 times book. This sets up a double-compounding scenario where book values grow as securities portfolios recover, and takeover multiples increase.
Here's the kicker: many of these banks are well-capitalized, profitable, and run by disciplined management teams. They're sitting ducks for larger, better-capitalized banks looking to expand their market footprint or diversify their loan portfolios.
The inefficiencies in this market are staggering, and investors willing to do the work can reap outsized rewards.
<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-holiday-24?utm_source=WebRD-1223">65% Off Benzinga Edge – Sale Ends December 31!</a>
<h2 class="wp-block-heading">Four Community Banks to Watch</h2>
1. Eagle Bancorp (EGBN): Based in Bethesda, Maryland, Eagle Bancorp operates in the lucrative Washington, D.C. market. The stock trades at just 70% of tangible book value, primarily due to concerns over commercial real estate exposure. However, the bank's portfolio leans toward higher-quality assets, and its market position in D.C. makes it an attractive acquisition target. With plenty of capital and a healthy 5.57% dividend yield, EGBN is a textbook example of value waiting to be unlocked.
2. Capitol Federal Financial (CFFN): Operating out of Topeka, Kansas, this is the epitome of a conservative bank. With 80% of its loans in single-family mortgages and non-performing assets at just 0.11% of total assets, CFFN is rock-solid. It trades at 79% of tangible book value and offers a 5.56% dividend yield. Insiders have been buying, and the bank's capital position is among the best in its peer group. This is the kind of quiet, sleepy bank that makes for an ideal acquisition target.
3. RBB Bancorp (RBB): Royal Business Bank, based in Los Angeles, serves a niche market within the Asian-American community. Its branches span strategic locations, including D.C., Chicago, Las Vegas, and Hawaii. With a strong loan portfolio and loyal deposits, RBB trades at 93% of tangible book value and offers a 2.98% dividend yield. This bank's focused strategy and profitability make it a highly attractive target for consolidation.
4. Northfield Bank (NFBK): Headquartered on Staten Island, Northfield operates 38 branches across the New York area. It trades at 75% of tangible book value and pays a 4.35% dividend. Despite past acquisition talks falling through, the bank's solid fundamentals and prime location ensure it remains a viable target. Non-performing assets are just 0.57%, underscoring its financial health and operational efficiency.
The Road Ahead
The inefficiencies in the community banking sector make it one of the last bastions of true value investing. As M&amp;A activity picks up and interest rates stabilize, the opportunity to profit from these overlooked gems will only grow. The double-compounding effect of increasing book values and higher takeover multiples could generate returns that far outpace the broader market.
So, this holiday season, consider giving yourself the gift of patience and discipline. Ignore the noise of instant experts and trendy stocks. Instead, focus on the quiet, undervalued corners of the market where real wealth is built. Community bank stocks may not be glamorous, but they offer something far more valuable: the potential for outsized, long-term gains.
Happy Holidays, and here's to a prosperous 2025!
Transform your trading strategy with Benzinga Edge. Get exclusive stock picks, daily trade setups, and real-time alerts. Last chance to save 65%—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-holiday-24?utm_source=WebRD-1223">Don't miss the End-of-Year Sale before it's gone!</a>
Photo by Yiorgos Ntrahas for Unsplash

Opinion

Your Christmas Roadmap to the Market's Most Hidden Profits

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday.
The Dow traded down 0.10% to 42,796.25 while the NASDAQ gained 0.72% to 19,713.64. The S&amp;P 500 also rose, gaining, 0.38% to 5,953.43.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42616196/jim-cramer-likes-walmart-recommends-buying-this-very-very-good-financial-stock">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a>
Leading and Lagging Sectors Information technology shares rose by 0.3% on Monday.
In trading on Friday, consumer staples shares fell by 1.1%.
Top Headline
U.S. durable goods orders fell 1.1% month-over-month to $285.1 billion in November compared to a revised 0.8% gain in October and versus market estimates of a 0.4% decline.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Traws Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRAW#NASDAQ">TRAW</a>) shares shot up 256% to $17.89 after the company announced progress in the development of Tivoxavir Marboxi.</li>
<li>Shares of Reliance Global Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>)got a boost, surging 192% to $3.5040 after the company issued a year-end review of its operations, as well as a look to the future.</li>
<li>Rumble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUM#NASDAQ">RUM</a>) shares were also up, gaining 70% to $12.16 after the company announced it has entered into a definitive agreement for a strategic investment of $775 million from Tether.</li>
</ul>
Equities Trading DOWN
<ul>
<li>iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) shares dropped 67% to $0.2945 after the company announced it voluntarily filed for Chapter 11 Bankruptcy.</li>
<li>Shares of MGO Global, Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) were down 60% to $0.3769 after the company announced the pricing of upsized $6.0 million public offering.</li>
<li>Castellum, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTM#NYSE">CTM</a>) was down, falling 31% to $0.4125 after the company announced the pricing of a $3.6 million registered direct offering of 9.47 million shares at $0.38 per share.</li>
</ul>
Commodities In commodity news, oil traded down 0.8% to $68.94 while gold traded down 0.7% at $2,626.70.
Silver traded up 0.3% to $30.050 on Monday, while copper fell 0.3% to $4.0870.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 gained 0.20%, Germany's DAX fell 0.13% and France's CAC 40 fell 0.08%. Spain's IBEX 35 Index fell 0.42%, while London's FTSE 100 rose 0.03%.
Asia Pacific Markets
Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 1.19%, Hong Kong's Hang Seng Index gaining 0.82%, China's Shanghai Composite Index declining 0.50% and India's BSE Sensex gaining 0.64%.
Economics
<ul>
<li>The Chicago Fed National Activity Index rose to -0.12 in November compared to a revised reading of -0.5 in October.</li>
<li>U.S. durable goods orders fell 1.1% month-over-month to $285.1 billion in November compared to a revised 0.8% gain in October and versus market estimates of a 0.4% decline.</li>
<li>U.S. building permits gained by 5.2% to an annualized rate of 1.493 million in November compared to initial estimates of 1.505 million.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42648003/how-to-earn-500-a-month-from-qualcomm-stock-2">How To Earn $500 A Month From Qualcomm Stock</a></li>
</ul>

Eurozone

Commodities

Intraday Update

Markets

AILE

MGOL

RELI

TRAW

Nasdaq Surges Over 100 Points, US Durable Goods Orders Decline In November

Luigi Mangione, the Ivy League grad <a href="https://www.benzinga.com/24/12/42541669/luigi-mangione-faces-murder-first-degree-life-in-prison-in-ceo-death-a-senseless-act-of-violence">accused of killing</a> UnitedHealthcare CEO Brian Thompson outside a New York Hilton on December 4, pled not guilty to state murder charges on Monday.
What Happened: Mangione faces 11 counts in New York, including first-degree murder, CNN <a href="https://www.cnn.com/2024/12/23/us/luigi-mangione-arraignment-new-york/index.html">reports</a>.
Veteran Manhattan prosecutor Joel Seidemann, assigned to the case by District Attorney Alvin Bragg, says the evidence against Mangione is substantial.
"I have never seen a case with such volume of evidence, aside from the issue of the quality of the evidence," Seidemann said during the proceeding. "This is not a usual case in terms of the thousands of hours of video."
Meanwhile, Mangione&#8217;s defense attorney Karen Friedman Agnifilo expressed concern about the possibility of a fair trial.
"He's a young man and he's being treated like a human ping pong ball by two warring jurisdictions here," Friedman Agnifilo said. "They're treating him like a human spectacle."
Why it Matters: Investigators allege that Mangione fled the crime scene on a bicycle, dumped his belongings in Central Park and left NYC on a bus.
The Maryland-born alumnus of the University of Pennsylvania was arrested in an Altoona, Pennsylvania McDonald&#8217;s on December 9. According to a criminal complaint, Mangione was found with a 3D-printed gun, a silencer and a fake ID.
A notebook found on Mangione in Altoona allegedly spoke negatively of the insurance industry and included a possible confession to the killing. ABC News <a href="https://abcnews.go.com/US/unitedhealthcare-ceo-shooting-suspect-inspired-unabomber-nypd-analysis/story?id=116653076">reported</a> that Mangione may have been inspired by Ted Kaczynski, also known as the Unabomber.
Mangione faced a highly publicized &#8220;perp walk&#8221; in his extradition to Manhattan on December 20. Mayor Eric Adams was seen walking closely behind Mangione following his arrival into the city, <a href="https://www.nytimes.com/2024/12/20/nyregion/luigi-mangione-eric-adams.html">according</a> to the New York Times.
Mangione&#8217;s alleged actions have drawn a polarizing response online. Several social media users expressed support of the killing, expressing outrage at the health insurance industry. Following the killing, Taylor Lorenz, a former Washington Post columnist, <a href="https://www.usermag.co/p/yes-we-want-insurance-executives">penned</a> a controversial Substack article titled, &#8220;Why &#8216;we&#8217; want insurance executives dead.&#8221;
Meanwhile, other commentators, such as New York Times columnist Bret Stephens, have <a href="https://www.nytimes.com/live/2024/12/04/opinion/thepoint/brian-thompson-luigi-mangione?smid=url-share">expressed</a> confoundment at Mangione&#8217;s online status as a &#8220;working class hero.&#8221; Mangione descended from a wealthy Maryland family and attended an elite college preparatory school. Meanwhile, Thompson grew up in rural Iowa and attended a public university.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42649864/tariffs-or-more-energy-analyst-warns-of-high-costs-limited-capacity-if-europe-bows-to-trumps-lng-push">Tariffs Or More Energy: Analyst Warns Of High Costs, Limited Capacity If Europe Bows To Trump&#8217;s LNG Push</a></li>
</ul>

Politics

Legal

Luigi Mangione, Suspected CEO Assassin, Pleads Not Guilty In New York Court

Evercore ISI Group analyst Cory Kasimov maintains BridgeBio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) with a Outperform and raises the price target from $45 to $50.

Price Target

BBIO

Evercore ISI Group Maintains Outperform on BridgeBio Pharma, Raises Price Target to $50

Innoviz Technologies Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVZ#NASDAQ">INVZ</a>) shares are trading higher Monday after the company announced a multi-year payment plan expected to <a href="https://www.benzinga.com/pressreleases/24/12/n42645310/innoviz-bolsters-financial-position-with-approx-80m-through-multi-year-nre-payment-plan-with-key-c">bolster its financial position</a>. 
What Happened: Innoviz said it entered into a multi-year&nbsp;NRE&nbsp;(Non-Recurring Engineering services) payment plan of&nbsp;approximately $80 million&nbsp;with key existing customers. 
$40 million&nbsp;is expected to be paid in 2025 with further amounts expected in 2026 and 2027.&nbsp;Innoviz said the payments will be incremental to revenues generated from ongoing sales of&nbsp;LiDAR&nbsp;products based on existing and new orders.
&#8220;NREs are essential to strategically funding our operations and reaching the start of production for several customers in 2026, and with this plan with our key customers we are poised to start 2025 from a position of financial strength,&#8221; said Omer Keilaf, founder and CEO of Innoviz. 
&#8220;We believe it is clear that our customers trust our ability to support the next generation of autonomous vehicles and meet their demands through Innoviz&#8217;s superior technology and ability to bring LiDARs to production. The expected NRE payments announced today, taken together with customer programs entering production, strengthen the financial foundation of the Company and position Innoviz to deliver significant value in the years to come.&#8221;
Check This Out: <a href="https://www.benzinga.com/24/12/42649864/tariffs-or-more-energy-analyst-warns-of-high-costs-limited-capacity-if-europe-bows-to-trumps-lng-push">Tariffs Or More Energy: Analyst Warns Of High Costs, Limited Capacity If Europe Bows To Trump&#8217;s LNG Push</a>
Innoviz said it will provide information regarding its 2025 outlook on its fourth quarter 2024 earnings call. The company is not reporting its quarterly earnings again until sometime in February. Analysts currently expect the company to report a loss of 14 cents per share and revenue of $5.86 million, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Innovix reported <a href="https://www.benzinga.com/calendars/earnings">third-quarter financial results</a> in November. The company ended the period with $87.7 million in total liquidity, consisting of cash and cash equivalents, bank deposits, marketable securities and short-term restricted cash.
INVZ Price Action: <a href="http://benzinga.com/quote/invz">Innoviz shares</a> were up 24.8% at $1.44 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

INVZ

What's Going On With Innoviz Technologies Stock Monday?

WIIM

Innoviz Technologies shares are trading higher after the company announced a multi-year Non-Recurring Engineering services payment plan of approximately $80 million with key existing customers.

Traws Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRAW#NASDAQ">TRAW</a>) shares are rocketing on Monday after the company disclosed advancements in the development of its one-dose investigational treatment <a href="https://www.benzinga.com/pressreleases/24/12/n42643864/traws-pharma-announces-progress-in-developing-tivoxavir-marboxil-for-h5n1-bird-flu" target="_blank" rel="noreferrer noopener">for H5N1 bird flu, tivoxavir marboxil</a>.
The Phase 1 trial was a randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, and pharmacokinetics (PK) of single-dose tivoxavir marboxil in healthy, influenza-negative adults.
Topline data revealed that a single dose maintained plasma drug levels above the EC90 for over 23 days, with results from a higher dose still pending.
Preclinical studies demonstrated that tivoxavir marboxil effectively inhibited drug-resistant influenza and highly pathogenic bird flu viruses both in vitro and in vivo. The company didn&#8217;t report any treatment-related adverse events.
Notably, the Type A H5N1 virus, first detected in U.S. dairy cattle in March 2024, has since spread to at least 866 herds across 16 states.
According to the U.S. Centers for Disease Control and Prevention, over 60 people in eight states have been infected, with the first severe U.S. case confirmed in December 2024.
C. David Pauza, PhD, Chief Science Officer said, &#8220;In laboratory testing, tivoxavir marboxil inhibited multiple isolates of highly pathogenic avian influenza H5N1. We evaluated the effects of drug treatment in mice exposed to human H5N1, where the virus was isolated from a dairy worker exposed to infected cattle,&#8221;
&#8220;Oral treatment with tivoxavir marboxil after the virus infection resulted in complete survival and lung virus levels below the limit of quantitation1. This result is highly encouraging for future clinical development of tivoxavir marboxil for treating human H5N1 influenza.&#8221;
Price Action: TRAW shares are up 147.5% at $12.41 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42651424" target="_blank" rel="noreferrer noopener">News Corp Sells Foxtel to DAZN for&nbsp;$2.12 Billion, Retains Stake in Global Sports Streaming</a></li>
</ul>
Photo: Shutterstock

Traws Pharma Stock Rockets On Promising H5N1 Bird Flu Treatment Results

The federal government&#8217;s massive real estate footprint faces scrutiny as Tesla CEO Elon Musk and former presidential candidate Vivek Ramaswamy prepare to <a href="https://www.benzinga.com/news/global/24/11/41927289/trump-appoints-elon-musk-and-vivek-ramaswamy-to-lead-doge-targeting-bureaucracy-and-65-trillion-federal-spending-we-will-not-go-gently">lead Donald Trump&#8217;s new Department of Government Efficiency, nicknamed DOGE</a>. Their mandate to slash federal bureaucracy could reshape office markets nationwide.
&#8220;The implications to the real estate industry in the U.S., now facing a pullback in federal demand, would be profound,&#8221; warned Brendan Wallace, CEO of Fifth Wall, in a CNBC interview last week. The federal government currently leases approximately 150 million square feet, costing $5 billion annually, with roughly half the leases cancelable within six months.
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>
While Washington D.C. would feel the heaviest impact from any federal space reduction, Wallace said the ripple effects would reach across the country. The timing proves particularly challenging for an office sector already grappling with existential questions about space demand.
However, some industry experts see potential opportunities amid the disruption. &#8220;Having someone come in from outside who can understand everything technology can do may be an opportunity to save money without threatening the current workforce,&#8221; suggests David Dworkin, president of the National Housing Conference, to Housing Wire.
See Also: Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
The initiative&#8217;s strict return-to-office mandate could trigger workforce changes. Musk and Ramaswamy&#8217;s Wall Street Journal op-ed embraces potential &#8220;voluntary terminations,&#8221; while simultaneously exploring options to monetize federal real estate assets through vehicles like REITs.
Beyond office space, Wallace identifies AI&#8217;s emerging influence on real estate markets as another factor. &#8220;The real estate industry is just now grappling with some of these big questions not just about how AI is going to make our business more efficient, but how it&#8217;s going to fundamentally change the business of real estate itself,&#8221; he explains.
Pat Cave, senior vice president at Enterprise Community Partners, argues against assuming negative outcomes. &#8220;I think the assumption that Trump is bad for housing is false,&#8221; he told Housing Wire, citing increased housing investments during Trump&#8217;s first term.
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
The initiative&#8217;s exact impact remains unclear, though housing agencies already face staffing challenges. Jung Choi of the Urban Institute notes both HUD and Ginnie Mae operate understaffed, potentially complicating program implementation, particularly for natural disaster response. The potential privatization of government-sponsored enterprises adds another layer of uncertainty. &#8220;I mean, it wasn&#8217;t directly mentioned by Trump himself, but then [Mark] Calabria and other people did suggest that GSEs should be released from their conservatorship,&#8221; Choi said, pointing to possible shifts in housing finance policy under the new administration.
As DOGE takes shape, its influence could <a href="https://www.benzinga.com/startups/24/12/42508653/bernie-sanders-supports-elon-musks-doge-stating-that-it-must-target-the-pentagons-886-billion-budget">extend beyond direct federal real estate holdings to shape broader market dynamics</a>, from office demand patterns to housing policy implementation.
Read Next:
<ul>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
<li>Unlock the hidden potential of commercial real estate —<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>

Real Estate

Elon Musk's DOGE Era: How Real Estate Could Be Different Under Trump's New Administration

In the current session, the stock is trading at $599.01, after a 2.35% increase. Over the past month, Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) stock increased by 4.16%, and in the past year, by 68.37%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1734975911_0.png" alt="Past Year Chart" />

<h3>Meta Platforms P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 51.3 in the Interactive Media &amp; Services industry, Meta Platforms Inc. has a lower P/E ratio of 27.62. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1734975911_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

A Look Into Meta Platforms Inc's Price Over Earnings

Deribit CEO Luuk Strijers has pointed to $84,000 as the &#8220;max pain&#8221; level for Bitcoin ahead of a <a href="https://www.benzinga.com/money/options">significant December options</a> expiry, suggesting the market could be pulled down to this level before finding new equilibrium.
Strijers&#8217; analysis highlights the unique dynamics of the upcoming quarterly expiry, which accounts for 44% of all outstanding Bitcoin options, making it the largest options expiry this year.
"The max pain level is $84,000, which is the typical indication of where to expect this expiry to end up in normal market circumstances," Strijers told Benzinga about the upcoming Dec. 27 expiry. 
He explained that max pain levels, derived from the strike price where most open interest resides, often act as a gravitational pull on the market during major expiries.
Bitcoin is currently trading at $93,100 levels, down 2.5% over the last 24 hours. Ether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) is trading at $3,270, down 1% for the day.
Other major altcoins like Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) are trading down 0.2%, 0.5% and 1.5%, respectively, according to data from CoinGecko.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42644568/institutional-crypto-adoption-for-real-this-time-says-messari">Institutional Crypto Adoption &#8216;For Real This Time,&#8217; Says Messari</a>
<h3 class="wp-block-heading">Market Magnetism And Expiry Dynamics</h3>
Strijers noted that the large expiry, with $14 billion of Bitcoin options set to expire, could act as a &#8220;magnet,&#8221; drawing Bitcoin prices closer to the $84,000 level. 
"This large expiry might pull the market down toward $84,000, and after Friday morning, we might see a release moment for the market to rebalance or refine its new destination," he said.
The unusual size of in-the-money options adds to the complexity. 
Strijers revealed that $4.3 billion worth of Bitcoin options—approximately 30% of the total—are currently in-the-money, a figure significantly higher than usual. 
In the context of options trading, an option is considered in-the-money (ITM) when it has intrinsic value. 
For call options, this means the current market price of the underlying asset (in this case, Bitcoin) is higher than the strike price of the option. 
Conversely, for put options, it means the market price is below the strike price.
This elevated level of in-the-money options necessitates delta hedging, which could contribute to increased volatility during and after the expiry.
Delta hedging is a strategy where traders adjust positions in the underlying asset to neutralize risk from price changes, often amplifying market volatility during major options expiries.
<h3 class="wp-block-heading">Bullish Long-Term Sentiment Despite Short-Term Pressure</h3>
While Strijers acknowledged the possibility of a temporary correction pulling Bitcoin prices lower, he emphasized the long-term bullish sentiment in the market. 
"Market circumstances are rather bullish, and upside potential remains high. The next major expiry in March sees strikes as high as $120,000 or even $150,000," he said, pointing to the significant open interest in higher strike calls.
Strijers also highlighted that the put-call ratio stands at 0.44, indicating a stronger preference for calls, which is generally a bullish indicator. 
A put-call ratio of 0.44 means that the volume of put options (bets on price decreases) is significantly lower than the volume of call options (bets on price increases). This indicates a bullish market sentiment, as more traders are speculating on Bitcoin's price rising rather than falling.
Despite the short-term pullback, Strijers said, "The market is not bearish at all. It's still positioned in a positive way."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42627116/bitcoin-ethereum-xrp-dogecoin-whipsaw-but-these-4-key-factors-make-it-a-hiccup-not-a-downturn">Bitcoin, Ethereum, XRP, Dogecoin Whipsaw, But These 4 Key Factors Make It A &#8216;Hiccup,&#8217; Not A Downturn</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$84,000 Is Bitcoin's Worst Case, Options Trading Firm CEO Says

DRCT

Direct Digital Shares Resume Trade Then Again Halted On Circuit Breaker To The Upside, Stock Now Up 514.5%

SG Holdings Co (JP:9143) has released an update. SG Holdings Co., Ltd. emphasizes its commitment to ‘Stakeholder Management' by enhancing service q...

SG Holdings Co. Reinforces Corporate Governance and Diversity

SG Holdings Co (JP:9143) has released an update. SG Holdings Co., Ltd. has announced a correction to their initial notification regarding the tende...

SG Holdings Amends Tender Offer Details

SG Holdings Co (JP:9143) has released an update. SG Holdings Co., Ltd. has announced the disposal of treasury shares as part of a performance-linke...

SG Holdings Announces Performance-Linked Stock Plan

SG Holdings Co (JP:9143) has released an update. SG Holdings Co., Ltd. has successfully completed a tender offer for shares of Chilled & Frozen Log...

SG Holdings Successfully Acquires Chilled & Frozen

SG Holdings Co (JP:9143) has released an update. SG Holdings Co. has announced an interim dividend of 26 yen per share, reflecting their commitment...

SG Holdings Announces Steady Interim Dividend

SG Holdings Co (JP:9143) has released an update. SG Holdings Co. has revised its earnings forecast for the fiscal year ending March 31, 2025, due t...

SG Holdings Adjusts Earnings Forecast Amid Business Variances

SG Holdings Co ( ($SGHHF) ) has released its Q2 earnings. Here is a breakdown of the information SG Holdings Co presented to its investors. SG Hold...

Comments

SG Holdings Co

매도 수량

SG Holdings Co (OTC:SGHHF) 주식, 공매도 수량 보고

뉴스

파트너 / 기고자

벤징가 글로벌